|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 239/48 | (2006.01) |
| C07D 239/48 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/506 | (2006.01) |
| (11) | Number of the document | 3788035 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19726240.5 |
| Date of filing the European patent application | 2019-05-03 | |
| (97) | Date of publication of the European application | 2021-03-10 |
| (45) | Date of publication and mention of the grant of the patent | 2024-08-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/030717 |
| Date | 2019-05-03 |
| (87) | Number | WO 2019/213606 |
| Date | 2019-11-07 |
| (30) | Number | Date | Country code |
| 201862667226 P | 2018-05-04 | US |
| (72) |
PANDEY, Anjali , US
NORTHEN, Julian Scott , GB
FERNANDES, Philippe , GB
CHEN, Ying , US
LU, Yuelie , US
KARABORNI, Sami , US
KODERSHA, Gus , US
|
| (73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | SOLID FORMS OF CERDULATINIB |
| SOLID FORMS OF CERDULATINIB |